is glp 1 bad for kidneys Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist attenuating renal fibrosis Potential kidney-protective and other effects

(2010) Effect of L-carnitine on diabetic neuropathy and ventricular dispersion in patients with diabetes mellitus

Typically administered weekly, they can be given intramuscularly or subcutaneously

Reference Bowers, C

Anti-Inflammatory Actions Chronic inflammation drives tissue degradation and interferes with proper healing

In contemporary clinical practice, patients with diabetes following pancreatic disease are frequently coded under non-specific ICD-10 categories such as E13 (other specified diabetes mellitus) or E11 (Type 2 diabetes mellitus), resulting in omission of pancreatic enzyme replacement therapy, inadequate nutritional rehabilitation, limited access to continuous glucose monitoring, and insufficient surveillance for pancreatic malignancy